Skip to content

Probiotics/TPN in the NICU

A Prospective/Retrospective Chart Review of the Effects of a Probiotic Dietary Supplement on Days of Total Parenteral Nutrition in Two Neonatal Intensive Care Units

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04977817
Enrollment
150
Registered
2021-07-27
Start date
2021-11-03
Completion date
2022-08-26
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Necrotizing Enterocolitis of Newborn, Total Parenteral Nutrition

Brief summary

The purpose of this study is to evaluate the effect of probiotic administration on TPN dependence in infants \< 32 weeks GA and BW 1500 grams or less in the Banner - University Medical Center Phoenix and Banner Children's at Desert Neonatal Intensive Care Units (NICU). The primary endpoint of capturing the number of days of TPN administration can reflect that an infant is progressing towards readiness for the initiation or advancement of enteral feedings at an earlier interval. The relationship between probiotic administration and the incidence of NEC, culture positive sepsis, and mortality is of interest to us and will be captured. Finally, the assessment of the tolerance of probiotic administration and the potential positive impact on growth and development in these premature infants may validate our current practices.

Interventions

DIETARY_SUPPLEMENTSimilac Probiotic Tri-Blend

Probiotic dietary supplement, Similac Probiotic Tri-Blend

Sponsors

Phoenix Children's Hospital
CollaboratorOTHER
Banner University Medical Center
CollaboratorOTHER
Pediatrix
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Birth weight \< 1500 grams or GA \< 32 weeks

Exclusion criteria

* Life threatening congenital anomalies * Transfers to another facility prior to discharge home * Investigator discretion to exclude if deemed necessary

Design outcomes

Primary

MeasureTime frameDescription
Number of days on total parenteral nutrition30 daysEvaluate the effects of a probiotic dietary supplement (Similac Probiotic Tri-Blend) on number of days on total parenteral nutrition (TPN) in infants admitted to the Neonatal Intensive Care Unit (NICU).

Secondary

MeasureTime frameDescription
Impact on neonatal growth30 daysNeonatal growth velocity may be impacted by the usage of probiotics in the Neonatal Intensive Care Unit.
Feeding Intolerance30 daysThe administration of probiotics may change the incidence of feeding intolerance

Other

MeasureTime frameDescription
Incidence of complication of central lines30 daysProbiotic administration may change the length of time that a central line will need to be in place.
Incidence of NEC30 daysProbiotic administration may change the incidence of Necrotizing Enterocolitis
All causes of Mortality30 daysProbiotic administration may change the incidence of mortality in the Neonatal Intensive Care Unit.
Days on Respiratory Support30 daysDays on respiratory support may represent an indication of overall outcomes in the Neonatal Intensive Care Unit
Incidence of culture positive sepsis30 daysProbiotic administration may change the incidence of culture positive sepsis

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026